title: Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio: call for consensus.
authors.forename: S
authors.initials: S
authors.lastname: Becker
authors.forename: A
authors.initials: A
authors.lastname: Fisher
authors.forename: C
authors.initials: C
authors.lastname: Flexner
authors.forename: J G
authors.initials: JG
authors.lastname: Gerber
authors.forename: R
authors.initials: R
authors.lastname: Haubrich
authors.forename: A D
authors.initials: AD
authors.lastname: Kashuba
authors.forename: A D
authors.initials: AD
authors.lastname: Luber
authors.forename: S C
authors.initials: SC
authors.lastname: Piscitelli
mesh_terms: D015658:HIV Infections / Q000188:drug therapy* / Q000378:metabolism / Q000821:virology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D020128:Inhibitory Concentration 50; D016896:Treatment Outcome
chemical_list: D017320:HIV Protease Inhibitors